Polymorphisms of Renin-Angiotensin System and Natriuretic Peptide Receptor A Genes in Patients of Greek Origin with a History of Myocardial Infarction

Abstract

We assessed the association between (CA)n repeat polymorphism of angiotensinogen (AGT), 250 base pair (bp) insertion/deletion (I/D) of angiotensin-converting enzyme (ACE), tetranucleotide repeat polymorphism (TCTG)n of renin (REN), (CT)n repeat polymorphism of the natriuretic peptide receptor A (NPRA) genes, and the presence and extent of coronary artery disease (CAD) in Greek patients with a history of myocardial infarction (MI). A total of 158 post-MI patients referred for coronary angiography were compared with 144 controls. The SS genotype of the AGT gene was related with an increased risk for 3-vessel CAD (odds ratio [OR], 1.94; 95% confidence interval [CI], 1.05-3.61; P = .041), whereas the SL genotype was related with a decreased risk (OR, 0.44; 95% CI, 0.22-0.87; P = .019). Moreover, there was a trend for the SL genotype of the REN gene toward increased risk for CAD. There was a significant association between (CA)n polymorphism of the AGT gene and the extent of CAD in Greek patients with a history of MI.

Keywords

polymorphism renin angiotensin natriuretic peptides myocardial infarction

References

Wilson JM Diagnosis and treatment of acquired coronary artery disease. Postgrad Med J. 2009;85(1005):364-365.

Hall AS , Sapsford R. , Megarry SG , Ball SG

Inhibition of the renin-angiotensin system after acute myocardial infarction-treat first, select later?

Heart. 1996;76(3 suppl 3):73-78.

Hammoud RA , Vaccari CS , Nagamia SH , Khan BV Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature. Vasc Health Risk Manag. 2007;3(6):937-945.

Prisant LM Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents. Am J Med. 2008;121(8 suppl):S8-S15.

van der Zander K. , Houben AJ , Kroon AA , de Leeuw PW Effects of brain natriuretic peptide on forearm vasculature: comparison with atrial natriuretic peptide. Cardiovasc Res. 1999;44(3):595-600.

Gardner DG , Chen S. , Glenn DJ , Grigsby CL Molecular biology of the natriuretic peptide system: implications for physiology and hypertension. Hypertension. 2007;49(3):419-426.

Sarzani R. , Salvi F. , Dessi-Fulgheri P. , Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens . 2008;26(5):831-843.

Hobbs A. , Foster P. , Prescott C. , Scotland R. , Ahluwalia A. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardio-protective role for endothelium-derived C-type natriuretic peptide. Circulation. 2004 ;110(10):1231-1235.

Dedoussis GV , Panagiotakos DB , Vidra NV , et al. Association between TNF-alpha -308G>A polymorphism and the development of acute coronary syndromes in Greek subjects: the CARDIO2000-GENE Study. Genet Med. 2005 ;7(6):411-416.

10.

Manginas A. , Tsiavou A. , Chaidaroglou A. , et al. Inflammatory cytokine gene variants in coronary artery disease patients in Greece. Coron Artery Dis. 2008;19(8):575-582.

11.

Casas JP , Shah T. , Hingorani AD , Danesh J. , Pepys MB C-reactive protein and coronary artery disease: a critical review. J Intern Med. 2008;264(4):295-314.

12.

Fytili P. , Giannatou E. , Papanikolaou V. , et al. Association of repeat polymorphisms in the estrogen receptors alpha, beta, and androgen receptor genes with knee osteoarthritis. Clin Genet. 2005; 68(3):268-277.

13.

Isa MN , Boyd E. , Morrison N. , Harrap S. , Clauser E. , Connor JM Assignment of the human angiotensinogen gene to chromosome 1q42-q43 by nonisotopic in situ hybridization. Genomics. 1990; 8(3):598-600.

14.

Jeunemaitre X. , Inoue I. , Williams C. , et al. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60(6): 1448-1460.

15.

Jeunemaitre X. , Soubrier F. , Kotelevtsev YV , et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992; 71(1):169-180.

16.

Sethi AA , Nordestgaard BG , Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 2003;23(7):1269-1275.

17.

Brewster UC , Setaro JF , Perazella MA The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci. 2003;326(1):15-24.

18.

Xu MQ , Ye Z. , Hu FB , He L. Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation. 2007;116(12):1356-1366.

19.

Cong ND , Hamaguchi K. , Saikawa T. , Hara M. , Sakata T. A polymorphism of angiotensinogen gene codon 174 and coronary artery disease in Japanese subjects. Am J Med Sci. 1998;316(5): 339-344.

20.

Gardemann A. , Stricker J. , Humme J. , et al. Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis. Atherosclerosis. 1999;145(2): 309-314.

21.

Olivieri O. , Stranieri C. , Girelli D. , et al. Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease. J Hypertens. 2001 ;19(5):879-884.

22.

Lanz JR , Pereira AC , Lemos PA , Martinez E. , Krieger JE Angiotensinogen M235T polymorphism is associated with coronary artery disease severity. Clin Chim Acta. 2005;362(1-2):176-181.

23.

Jeunemaitre X. , Ledru F. , Battaglia S. , et al. Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study. Hum Genet. 1997;99(1):66-73.

24.

Rigat B. , Hubert C. , Alhenc-Gelas F. , Cambien F. , Corvol P. , Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86(4):1343-1346.

25.

Tiret L. , Rigat B. , Visvikis S. , et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51(1):197-205.

26.

Nakai K. , Itoh C. , Miura Y. , et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 1994;90(5):2199-2202.

27.

Sigusch HH , Vogt S. , Gruber U. , et al. Angiotensin-I-converting enzyme DD genotype is a risk factor of coronary artery disease. Scand J Clin Lab Invest. 1997;57(2):127-132.

28.

Cambien F. , Costerousse O. , Tiret L. , et al. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90(2):669-676.

29.

Ludwig E. , Corneli PS , Anderson JL , Marshall HW , Lalouel JM , Ward RH Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 1995;91(8):2120-2124.

30.

Eichner JE , Christiansen VJ , Moore WE , Dunn ST , Schechter E. Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients. Atherosclerosis. 2001;154(3): 673-679.

31.

Seckin D. , Ilhan N. , Ozbay Y. The relationship between ACE insertion/deletion polymorphism and coronary artery disease with or without myocardial infarction. Clin Biochem. 2006;39(1):50-54.

32.

Friedl W. , Krempler F. , Paulweber B. , Pichler M. , Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis . 1995;112(2):137-143.

33.

Lindpaintner K. , Pfeffer MA , Kreutz R. , et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332(): 706-711.

34.

Agerholm-Larsen B. , Nordestgaard BG , Steffensen R. , Sorensen TI , Jensen G. , Tybjaerg-Hansen A. ACE gene polymorphism: ischemic heart disease and longevity in 10,150 individuals. A case-referent and retrospective cohort study based on the Copenhagen City Heart Study. Circulation. 1997;95(10):2358-2367.

35.

Suzuki T. , Yokota H. , Yamazaki T. , et al. Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coron Artery Dis . 1996;7(5):371-375.

36.

Oei HH , Sayed-Tabatabaei FA , Hofman A. , Oudkerk M. , van Duijn CM , Witteman JC The association between angiotensin-converting enzyme gene polymorphism and coronary calcification. The Rotterdam Coronary Calcification Study. Atherosclerosis. 2005;182(1):169-173.

37.

Hasimu B. , Nakayama T. , Mizutani Y. , et al. A novel variable number of tandem repeat polymorphism of the renin gene and essential hypertension. Hypertens Res. 2003;26(6):473-477.

38.

Tsezou A. , Karayannis G. , Giannatou E. , Papanikolaou V. , Triposkiadis F. Association of renin-angiotensin system and natriuretic peptide receptor A gene polymorphisms with hypertension in a Hellenic population. J Renin Angiotensin Aldosterone Syst. 2008;9(4):202-207.

39.

Knowles JW , Erickson LM , Guy VK , Sigel CS , Wilder JC , Maeda N. Common variations in noncoding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet. 2003;112(1):62-70.

40.

Rubattu S. , Bigatti G. , Evangelista A. , et al. Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol. 2006;48(3):499-505.

41.

Usami S. , Kishimoto I. , Saito Y. , et al. Association of CT dinucleotide repeat polymorphism in the 5'-flanking region of the guanylyl cyclase (GC)-A gene with essential hypertension in the Japanese. Hypertens Res. 2008;31(1):89-96.